Your session is about to expire
← Back to Search
SBRT for Adenoid Cystic Carcinoma
Study Summary
This trial is studying how well SBRT works in treating patients with adenoid cystic carcinoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2024 Phase 2 trial • 57 Patients • NCT03004183Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can take care of myself and am up and about more than half of the day.I am 18 years old or older.I need urgent surgery for cancer spread to my brain or spine.I have cancer spread to my thigh bone and need surgery to stabilize it.I have fluid buildup due to cancer in the lining of my lung.I have 1 to 5 areas where cancer has spread, including in bones or brain.My primary cancer has not worsened in the last 6 months.All my cancer spots can be treated with targeted radiation, as confirmed by a specialist.I have a cancer spot that can be treated with targeted therapy like radiation or ablation.I haven't had cancer drugs or targeted therapy in the last 4 weeks.I have at least one cancer site that's not in the bones.I have adenoid cystic carcinoma with distant metastases.I have another cancer besides skin or low-risk prostate cancer that is not in remission.I have confirmed I am not pregnant and will use effective birth control during and after treatment.I have received treatment for adrenal cancer within the last 4 weeks.My treated cancer spread is under control or can be treated with SBRT if not controlled.I do not have any severe illnesses or social situations that would stop me from following the study's requirements.I've had treatments like ablation or embolization for cancer spread and am now set for SBRT.My brain lesion is 3 cm or smaller.All my cancer sites cannot be treated.
- Group 1: Standard of Care (Cohort 1)
- Group 2: Stereotactic Body Radiotherapy (SBRT) 1-5 Metastatic Sites (Cohort 1)
- Group 3: Local Ablative Therapy (Cohort 2)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What objectives is this research project seeking to accomplish?
"The main goal of the research, which will be monitored over a 5 year period from randomization to local progression or death, is to assess Local Control Rate (Cohort 2). Secondary objectives include gauging Overall Survival using RECIST v1.1 and Kaplan-Meier techniques, determining Toxicity Rates with Common Terminology Criteria for Adverse Events version 5.0 and Quality of Life evaluations through FACT-G descriptive statistic methods."
Is this medical investigation currently recruiting participants?
"Affirmative. According to clinicaltrials.gov, recruitment for this trial is still open after it was first posted on December 27th 2021 and last updated September 20th 2022. 66 applicants are needed at 3 separate sites."
What is the participant count for this investigation?
"Affirmative. According to records on clinicaltrials.gov, this trial is presently recruiting volunteers and has been since December 27th 2021. 66 individuals are needed from 3 different medical centers for the current iteration of the study that was last updated in September 2022."
Share this study with friends
Copy Link
Messenger